VEGFC and ovarian carcinoma: Consistently, Huang and Sui (9) showed that the positive rate of MMP-2, vascular endothelial growth factor C (VEGF-C) and E-cadherin in ovarian cancer is higher than that in benign and borderline ovarian tumors.